Table 1—

Risk for endothelial dysfunction

TertilesOR (95% CI)
123
Log(OPG)
    Model 112.5 (0.9–6.7)5.2 (1.9–14.1)*
    Model 212.3 (0.8–6.7)6.3 (1.9–20.7)*
    Model 312.7 (0.8–8.9)5.4 (1.4–20.4)
Log(hsCRP)
    Model 111.3 (0.5–3.6)1.2 (0.5–2.8)
    Model 211.5 (0.5–4.4)1.6 (0.6–4.3)
    Model 311.7 (0.5–5.3)2.0 (0.7–5.9)
  • Model 1: unadjusted. Model 2: adjusted for age, sex, BMI, hypertension, smoking, and albuminuria. Model 3: adjusted for the variables in model 2 plus hsCRP, HOMA-IR, and antidiabetic and cardiovascular medication (including insulin, peroxisome proliferator–activated receptor γ agonist, ACE inhibitor, angiotensin receptor blocker, and statin).

  • Model 3: adjusted for the variables in model 2 plus HOMA-IR and antidiabetic and cardiovascular medication.

  • *

    * P < 0.01;

  • P < 0.05.